Sign up to our newsletter Subscribe
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
Value, Affordability and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures
